Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes

Gut

Volumn 48, Issue 1, 2001, Pages 1-5

  Houlston, R ^a   Crabtree, M ^b,c   Phillips, R ^b   Tomlinson, I ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; GENE PRODUCT;

ADENOMATOUS POLYP; AUTOSOMAL DOMINANT INHERITANCE; DISEASE SEVERITY; DNA MODIFICATION; FAMILIAL DISEASE; GENE MUTATION; GERM LINE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ADENOMATOUS POLYPOSIS COLI; COLECTOMY; COLONOSCOPY; GENES, APC; GENOTYPE; GERM-LINE MUTATION; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0035173781     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.1.1     Document Type: Review

References (48)

1. Dimer formation by an N-terminal coiled coil in the APC protein
2. Association of the APC gene product with beta-catenin
3. The adenomatous polyposis coli (APC) tumor suppressor
4. Functional interaction of an axin homolog, conductin, with beta-catenin, APC and GSK3
5. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
6. Tumor-suppressor gene products in cell contacts: The cadherin-APC-armadillo connection
7. A new Drosophila APC homologue associated with adhesive zones of epithelial cells
8. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
9. APC: The plot thickens
10. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways
11. Phenotypic expression in familial adenomatous polyposis: Partial prediction by mutation analysis
12. APC genotype, polyp number, and surgical options in familial adenomatous polyposis
13. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation
14. Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes
15. Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9
16. Colorectal polyp counts and cancer risk in familial adenomatous polyposis
17. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis
18. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients
19. Upper gastrointestinal cancer in patients with familial adenomatous polyposis
20. Alleles of the APC gene: An attenuated form of familial polyposis
21. Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the APC gene. A clue for understanding the function of the APC protein
22. APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis
23. Genotype-phenotype correlations in attenuated adenomatous polyposis coli
24. A family with attenuated familial adenomatous polyposis due to a mutation in the alternatively spliced region of APC exon 9
25. Severe upper gastrointestinal polyposis associated with sparse colonic polyposis in a familial adenomatous polyposis family with an APC mutation at codon 1520
26. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
27. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history
28. Dominant negative effect of the APC1309 mutation: A possible explanation for genotype-phenotype correlations in familial adenomatous polyposis
29. Biology of the adenomatous polyposis coli tumor suppressor
30. The type of somatic mutation at APC in FAP is determined by the site of the germline mutation: A new facet to Knudson's 'two-hit' hypothesis
31. Familial adenomatous polyposis: Desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444
32. Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP)
33. Inherited susceptibility to colorectal adenomas and carcinomas: Evidence for a new predisposition gene on 15q14-q22
34. Attenuated adenomatous polyposis coli: The role of ascertainment bias through failure to dye-spray at colonoscopy
35. The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior
36. Surgery, desmoid tumors, and familial adenomatous polyposis: Case report and literature review
37. Mutagenicity of bile and duodenal adenomas in familial adenomatous polyposis
38. A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36
39. Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis
40. Variants at the secretory phospholipase A2 (PLA2G2A) locus: Analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours
41. Identification of a modifier gene locus on chromosome 1p35-36 in familial adenomatous polyposis
42. Modifier genes in humans: Strategies for identification
43. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes
44. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse
45. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia
46. A genetic model for colorectal tumorigenesis
47. Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC
48. Transcript dosage effect in familial adenomatous polyposis: Model offered by two kindreds with exon 9 APC gene mutations